J2KBIO Statistics

Total Valuation

J2KBIO has a market cap or net worth of KRW 62.98 billion. The enterprise value is 53.53 billion.

Market Cap	62.98B
Enterprise Value	53.53B

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

J2KBIO has 5.85 million shares outstanding. The number of shares has increased by 9.44% in one year.

Current Share Class	5.85M
Shares Outstanding	5.85M
Shares Change (YoY)	+9.44%
Shares Change (QoQ)	+2.73%
Owned by Insiders (%)	62.03%
Owned by Institutions (%)	6.75%
Float	2.22M

Valuation Ratios

The trailing PE ratio is 21.18.

PE Ratio	21.18
Forward PE	n/a
PS Ratio	1.93
PB Ratio	2.01
P/TBV Ratio	2.04
P/FCF Ratio	n/a
P/OCF Ratio	14.90
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.73, with an EV/FCF ratio of -19.11.

EV / Earnings	18.52
EV / Sales	1.64
EV / EBITDA	12.73
EV / EBIT	18.05
EV / FCF	-19.11

Financial Position

The company has a current ratio of 5.18, with a Debt / Equity ratio of 0.04.

Current Ratio	5.18
Quick Ratio	4.27
Debt / Equity	0.04
Debt / EBITDA	0.29
Debt / FCF	-0.44
Interest Coverage	34.81

Financial Efficiency

Return on equity (ROE) is 9.88% and return on invested capital (ROIC) is 5.89%.

Return on Equity (ROE)	9.88%
Return on Assets (ROA)	5.23%
Return on Invested Capital (ROIC)	5.89%
Return on Capital Employed (ROCE)	9.11%
Revenue Per Employee	592.51M
Profits Per Employee	52.55M
Employee Count	55
Asset Turnover	0.92
Inventory Turnover	7.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.98% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-65.98%
50-Day Moving Average	11,426.20
200-Day Moving Average	12,784.70
Relative Strength Index (RSI)	47.27
Average Volume (20 Days)	214,480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, J2KBIO had revenue of KRW 32.59 billion and earned 2.89 billion in profits. Earnings per share was 508.44.

Revenue	32.59B
Gross Profit	12.30B
Operating Income	2.97B
Pretax Income	3.15B
Net Income	2.89B
EBITDA	4.20B
EBIT	2.97B
Earnings Per Share (EPS)	508.44

Full Income Statement

Balance Sheet

The company has 10.67 billion in cash and 1.22 billion in debt, giving a net cash position of 9.44 billion or 1,615.14 per share.

Cash & Cash Equivalents	10.67B
Total Debt	1.22B
Net Cash	9.44B
Net Cash Per Share	1,615.14
Equity (Book Value)	31.32B
Book Value Per Share	5,374.70
Working Capital	15.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.23 billion and capital expenditures -7.03 billion, giving a free cash flow of -2.80 billion.

Operating Cash Flow	4.23B
Capital Expenditures	-7.03B
Free Cash Flow	-2.80B
FCF Per Share	-479.07

Full Cash Flow Statement

Margins

Gross margin is 37.75%, with operating and profit margins of 9.10% and 8.87%.

Gross Margin	37.75%
Operating Margin	9.10%
Pretax Margin	9.66%
Profit Margin	8.87%
EBITDA Margin	12.90%
EBIT Margin	9.10%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 1.86%.

Dividend Per Share	200.00
Dividend Yield	1.86%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-9.44%
Shareholder Yield	-7.59%
Earnings Yield	4.59%
FCF Yield	-4.45%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

J2KBIO has an Altman Z-Score of 13.18.

Altman Z-Score	13.18
Piotroski F-Score	n/a